The Latest in Latest News

FDA’s Stricter Regulation of Lab-Developed Tests Faces Lawsuits and Lingering Concerns

September 24, 2024

Practice Management

FDA Expands Indication for Amivantamab in Lung Cancer

September 23, 2024

Black Women Have a Higher Risk for Death in BC Subtypes

September 23, 2024

FDA OKs Adjuvant Ribociclib in Earlier Stage Breast Cancer

September 23, 2024

Melanoma: Neoadjuvant Immunotherapy Provides Optimal Survival Results

September 23, 2024

Identifying Drug-Induced Rashes in Skin of Color: Heightened Awareness Can Accelerate Diagnosis

September 23, 2024

Diversity in Medicine

FDA Initiative Aims to Improve Diversity in Clinical Trials

September 23, 2024

Diversity in Medicine

Are You Using the Correct Medication or a Look-Alike?

September 20, 2024

Practice Management

Cancer Risk: Are Pesticides the New Smoking?

September 20, 2024

A CRC Blood Test Is Here. What Does it Mean for Screening?

September 20, 2024

Fecal Immunochemical Test Performance for CRC Screening Varies Widely

September 19, 2024

When You and Your Malpractice Insurer Disagree on Your Case

September 18, 2024

Practice Management

Is Minimal Access Nipple-Sparing Mastectomy a Safer Option?

September 17, 2024

Should Genetic Testing Be Routine for Breast Cancer?

September 17, 2024

AI-Powered Clinical Documentation Tool Reduces EHR Time for Clinicians

September 17, 2024

Practice Management